This enduring material activity will provide an overview of the SVU’s guidelines for cross-training sonographers credentialed in other ultrasound specialties in vascular ultrasound and technology.  

This enduring material activity will discuss lower extremity venous insufficiency, processes and protocols for performing ultrasounds. 

This issue contains a review on cerebral vasomotor reactivity testing using transcranial Doppler in COVID patients, a review on the decrease in endothelial function in peripheral arteries and the influence of aging, a review on screening for subclavian artery stenosis, and a report on catheter misplacement following subclavian vein catheterization.

This issue contains a review on cerebral vasomotor reactivity testing using transcranial Doppler in COVID patients, a review on the decrease in endothelial function in peripheral arteries and the influence of aging, a review on screening for subclavian artery stenosis, and a report on catheter misplacement following subclavian vein catheterization.

This issue contains a review on cerebral vasomotor reactivity testing using transcranial Doppler in COVID patients, a review on the decrease in endothelial function in peripheral arteries and the influence of aging, a review on screening for subclavian artery stenosis, and a report on catheter misplacement following subclavian vein catheterization.

This issue contains a review on cerebral vasomotor reactivity testing using transcranial Doppler in COVID patients, a review on the decrease in endothelial function in peripheral arteries and the influence of aging, a review on screening for subclavian artery stenosis, and a report on catheter misplacement following subclavian vein catheterization.

This online webinar provides an update on the diagnostic criteria based on the cytogenetic and genomics of multiple myeloma, benefits and risks of frontline therapy, consolidation, and maintenance therapy options, sequencing therapies, CAR-modified T-cell therapy, bispecific antibody constructs, and antibody-drug conjugate (ADC) based treatment for patients with multiple myeloma.

There is an unmet need to develop newer therapies beyond targeting AR signaling for mCRPC. PARP inhibitors are targeted agents that treat HRR-deficient tumors. Olaparib, rucaparib, niraparib, veliparib, and talazoparib were evaluated in phase trials as monotherapy and with combinations for mCRPC. The combination approach has shown impressive early efficacy signals in clinical settings and appears poised for a breakthrough.

This webinar will discuss complex abdominal aortic aneurysms and the different types of subsequent endovascular repairs and the role of follow up duplex ultrasound imaging. 

Ovarian cancer (OC) is often diagnosed at an advanced stage and has generally poor survival rates­—even after aggressive surgical management and chemotherapy. Without maintenance therapy, approximately 70% of patients relapse within 3 years of treatment. Recent clinical trials of polyadenosine diphosphate-ribose polymerase (PARP) inhibitors have demonstrated substantial efficacy as maintenance therapy for OC patients. Additionally, clinical evidence suggests that daily monitoring of patients rec...